Aimmune Therapeutics, Inc. announced the expansion of its Scientific Advisory Board with the appointments of George du Toit, M.B., B.Ch., a Professor of Paediatric Allergy at King’s College London, Guy’s and St. Thomas’ NHS Foundation Trust, and Wayne G. Shreffler, M.D., Ph.D., Chief of Pediatric Allergy and Immunology and Director of the Food Allergy Center at Massachusetts General Hospital and Associate Professor of Pediatrics at Harvard Medical School. Both Prof. du Toit and Dr. Shreffler are principal investigators for Aimmune’s recently completed PALISADE and follow-on ARC004 Phase 3 clinical trials of AR101.